AB Science ABSCF Stock
AB Science Price Chart
AB Science ABSCF Financial and Trading Overview
| AB Science stock price | 1.12 USD |
| Previous Close | 1.12 USD |
| Open | 2.7 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 2.7 - 2.7 USD |
| 52 Week Range | 1.12 - 2.7 USD |
| Volume | 1.45K USD |
| Avg. Volume | 18 USD |
| Market Cap | 78.15M USD |
| Beta (5Y Monthly) | 1.183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ABSCF Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 66.566765 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
AB Science Stock Price History
| Beta (5Y Monthly) | 1.183 |
| 52-Week Change | -30.00000000000000000000000000000000% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 2.7 USD |
| 52 Week Low | 1.12 USD |
| 50-Day Moving Average | 1.3 USD |
| 200-Day Moving Average | 1.33 USD |
ABSCF Share Statistics
| Avg. Volume (3 month) | 18 USD |
| Avg. Daily Volume (10-Days) | 19 USD |
| Shares Outstanding | 69.78M |
| Float | 21.02M |
| Short Ratio | N/A |
| % Held by Insiders | 29.21% |
| % Held by Institutions | 0.0040% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -132.62% |
| Operating Margin (ttm) | 510.92% |
| Gross Margin | 83.30% |
| EBITDA Margin | 87.98% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.17M USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | 28.69% |
| Gross Profit (ttm) | 978K USD |
| EBITDA | 1.03M USD |
| Net Income Avi to Common (ttm) | -1557000 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | -0.4836196 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of AB Science
| Country | United States |
| State | N/A |
| City | Paris |
| Address | 3, Avenue George V |
| ZIP | 75008 |
| Phone | 33 1 47 20 00 14 |
| Website | https://www.ab-science.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cancers in France. The company's lead drug candidate is masitinib, a selective protein kinase inhibitor that targets mast cells and microglia in Phase 3 trial for the treatment of amyotrophic lateral sclerosis, progressive forms of multiple sclerosis, Alzheimer's disease, and indolent systemic mastocytosis, as well as in Phase 2 trial for mast cell activation syndrome and sickle cell disease. It also develops AB8939, a microtubule destabilizer in Phase 1 trial for the treatment of acute myeloid leukemia; and AB12319 in preclinical trial to treat sarcoma and solid tumors. In addition, the company markets its masitinib under the Masivet brand for the treatment of mast cell tumors in dogs in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Q&A For AB Science Stock
What is a current ABSCF stock price?
AB Science ABSCF stock price today per share is 1.12 USD.
How to purchase AB Science stock?
You can buy ABSCF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AB Science?
The stock symbol or ticker of AB Science is ABSCF.
Which industry does the AB Science company belong to?
The AB Science industry is Drug Manufacturers - Specialty & Generic.
How many shares does AB Science have in circulation?
The max supply of AB Science shares is 69.78M.
What is AB Science Price to Earnings Ratio (PE Ratio)?
AB Science PE Ratio is now.
What was AB Science earnings per share over the trailing 12 months (TTM)?
AB Science EPS is -0.03 USD over the trailing 12 months.
Which sector does the AB Science company belong to?
The AB Science sector is Healthcare.